News Releases

Date Title and Summary Additional Formats
Toggle Summary HTG Molecular Diagnostics Secures Senior Term Loan from Silicon Valley Bank
TUCSON, Ariz. , June 25, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has entered into a $10.0 million senior term loan agreement with Silicon Valley Bank (SVB), the
View HTML
Toggle Summary HTG EdgeSeq Technology Highlighted in Multiple Posters Presented by Pharma Partners at the 2020 American Association for Cancer Research Virtual Meeting
TUCSON, Ariz. , June 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced its HTG EdgeSeq technology was highlighted in multiple posters presented by global pharma company partners
View HTML
Toggle Summary HTG Introduces the HTG EdgeSeq Pan B-Cell Lymphoma Panel
Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas TUCSON, Ariz. , June 18, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch
View HTML
Toggle Summary HTG Adds Three New Distributors in Europe, Expanding and Strengthening Reach in the Nordics and Eastern Europe
TUCSON, Ariz. , June 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of three new European distributor agreements to promote HTG products and services in Nordic and
View HTML
Toggle Summary HTG EdgeSeq Technology Highlighted in Several Posters at ASCO
Posters span each of HTG’s customer types, including Pharma, Academic and Transmed, and several geographies TUCSON, Ariz. , June 02, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced
View HTML
Toggle Summary HTG Molecular Diagnostics Reports First Quarter 2020 Results
Call scheduled for today, May 13, at 4:30pm ET TUCSON, Ariz. , May 13, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31,
View HTML
Toggle Summary HTG Molecular Diagnostics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 13
TUCSON, Ariz. , May 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the first quarter ended March 31, 2020 after the market close on
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Full Year 2019 Results
Increased product and product-related services revenue over prior year, benefitting from expanded menu of profiling assays and increased number of customers adopting technology Released new HTG EdgeSeq Reveal data analysis software (version 2.0.0) Call scheduled for today, March 25 , at 4:30pm ET
View HTML
Toggle Summary HTG Molecular Diagnostics to Announce Year End 2019 Financial Results and Host Conference Call on Wednesday, March 25
TUCSON, Ariz. , March 17, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the year ended December 31, 2019 after the market close on Wednesday
View HTML
Toggle Summary HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference
TUCSON, Ariz. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the SVB Leerink 9 th Annual
View HTML